Medtronic reports third quarter fiscal 2024 financial results

Delivers on commitments with strong growth in Core Spine, Cardiac Surgery, Structural Heart, Cardiac Pacing, and across many international markets; Diabetes increases double digits as U.S. business...

Related Keywords

Dublin ,Ireland ,Australia ,United States ,Japan ,Switzerland ,New Zealand ,Canada ,Puerto Rico ,Israel ,Israeli ,America ,Swiss ,Erika Winkels ,Ryan Weispfenning ,Geoff Martha ,Nitron Cryoconsole ,Prnewswire Medtronic ,Karen Parkhill ,Medtronic ,European Union ,Central Lod District Court ,Inc Exp ,Pelvic Health ,Medtronic Inc ,Renal Care Solutions ,Our Mission ,Linkedin ,Ablation Solutions ,Peripheral Vascular Health ,Exchange Commission ,Us Tax Court ,Core Spine ,Cardiac Surgery ,Structural Heart ,Cardiac Pacing ,Patient Monitoring ,Respiratory Interventions ,Simplera Sync ,Cardiovascular Portfolio ,Cardiac Rhythm ,Heart Failure ,Peripheral Vascular ,Cardiac Rhythm Management ,Cardiac Pacing Therapies ,Cardiac Ablation Solutions ,Western Europe ,Vascular Embolization ,Neuroscience Portfolio ,Spinal Technologies ,Specialty Therapies ,Brain Modulation ,Pain Stim ,Medical Surgical Portfolio ,Medical Surgical ,General Surgical Technologies ,Advanced Surgical Technologies ,Acute Care ,Investor Events ,Transition Manufacturing Agreements ,Emerging Markets ,Middle East ,Latin America ,Eastern Europe ,Swiss Cantonal ,Private Securities Litigation Reform Act ,Annual Report ,Markets ,